SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Xero Limited (XROLF) trades at a trailing P/E of 34.7, forward P/E of 35.4. Trailing earnings yield is 2.89%, forward earnings yield 2.83%. PEG 0.87 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (40/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- PEG Ratio 0.87 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 2.89% — below bond yields — investors are paying a premium for expected growth rather than current earnings.
Overall SharesGrow Score: 57/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
40/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — XROLF
Valuation Multiples
P/E (TTM)34.7
Forward P/E35.4
PEG Ratio0.87
Forward PEG0.93
P/B Ratio0.00
P/S Ratio4.12
EV/EBITDA0.0
Per Share Data
EPS (TTM)$1.47
Forward EPS (Est.)$1.44
Book Value / Share$0.00
Revenue / Share$12.36
FCF / Share$0.00
Yields & Fair Value
Earnings Yield2.89%
Forward Earnings Yield2.83%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-0.56 |
$190.45M |
$-75.85M |
-39.8% |
| 2017 |
$-0.47 |
$278.14M |
$-65.02M |
-23.4% |
| 2018 |
$-0.17 |
$375.69M |
$-23.02M |
-6.1% |
| 2019 |
$-0.18 |
$516.11M |
$-25.34M |
-4.9% |
| 2020 |
$0.02 |
$699.61M |
$3.33M |
0.5% |
| 2021 |
$-2.70 |
$859.59M |
$19.69M |
2.3% |
| 2022 |
$-0.06 |
$1.12B |
$-9.29M |
-0.8% |
| 2023 |
$-0.74 |
$1.37B |
$-110.93M |
-8.1% |
| 2024 |
$1.05 |
$1.57B |
$160.21M |
10.2% |
| 2025 |
$1.47 |
$1.91B |
$207.03M |
10.8% |
